[
  {
    "ts": null,
    "headline": "Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=98cc9c5f11acaaa602468983a9efab16a892b7985619b0773e3cdb92bc7e23d4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754670960,
      "headline": "Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains",
      "id": 136298794,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=98cc9c5f11acaaa602468983a9efab16a892b7985619b0773e3cdb92bc7e23d4"
    }
  },
  {
    "ts": null,
    "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
    "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
    "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754656980,
      "headline": "Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?",
      "id": 136266976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.",
      "url": "https://finnhub.io/api/news?id=8df2967993ccaba27de452a17584b35aedf13d852173aca45f61e3cedb8ce6e3"
    }
  },
  {
    "ts": null,
    "headline": "Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence",
    "summary": "Agilent remains a strong life science leader with solid financials and strategic resilience, but near-term headwinds temper upside. See why A stock is a hold.",
    "url": "https://finnhub.io/api/news?id=cb5ed25640a6ecd310d6e9800b63a4d642c5006335cc918e2aaec265e971e12f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754637007,
      "headline": "Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence",
      "id": 136265607,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1206035004/image_1206035004.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Agilent remains a strong life science leader with solid financials and strategic resilience, but near-term headwinds temper upside. See why A stock is a hold.",
      "url": "https://finnhub.io/api/news?id=cb5ed25640a6ecd310d6e9800b63a4d642c5006335cc918e2aaec265e971e12f"
    }
  }
]